How we prove an inositol lot is myo-inositol
Identity is established in layers: appearance and solubility, IR and melting point, HPLC retention time and assay, and an isomer-specific check that separates myo-inositol from D-chiro and other cyclitols. An assay of 99.0–101.0% can be met by a different isomer or a sugar alcohol if the method does not resolve them. The certificate has to show which layer was tested and what the method could see.
An assay percentage is not an identity; the solid form, the retention time and the isomer ratio have to agree.
Four layers of identity
A single test rarely proves a molecule. The useful release file builds identity from tests that fail in different ways, so a coincidence in one layer does not carry the conclusion alone.
| Layer | Test | What it proves | What it misses |
|---|---|---|---|
| Appearance and solubility | Visual; water solubility | Consistency with the grade | Not specific to any molecule |
| Solid form | IR spectroscopy | Functional groups and fingerprint | Cannot quantify an isomer |
| Thermal identity | Melting point, 224–227 °C | Crystalline solid form | A mixture can broaden or depress it |
| Chromatographic identity | HPLC with RI or ELSD | Amount at a retention time | Co-elution with a similar polyol |
| Isomer identity | Isomer-resolving HPLC or NMR | Myo versus D-chiro and other cyclitols | Needs a suitable standard and method |
| Adulterant screen | HPLC, XRD or both | Sugar or sugar-alcohol carry-over | Nothing below the stated limit |
Identity is the agreement between the layers, not one result in isolation. An IR spectrum and a melting point that match the reference, an assay on the expected retention time and an isomer check that finds no D-chiro form a stronger file than three assay repeats.
The isomer ratio, not just the assay
Myo-inositol and D-chiro-inositol are stereoisomers: the same formula, C₆H₁₂O₆, and the same molecular mass, with the hydroxyl groups arranged differently around the ring. Myo-inositol is the meso form and is optically inactive; D-chiro-inositol is chiral and optically active. A total inositol assay that does not resolve the two cannot tell a myo drum from a D-chiro drum, or from a blend of both.
An isomer-resolving HPLC method needs a column and mobile phase that separate the peaks, a standard for each isomer, and a stated resolution. A single peak at the retention time of a myo standard is weak evidence if the method has never been shown to separate D-chiro. Spiking the sample with a small D-chiro standard, or running standard addition, is a practical way to show whether the method can see the second peak.
A polarimeter reading is a useful screen: a myo-inositol lot should be optically inactive, while a D-chiro fraction rotates plane-polarised light. The reading is not an assay and it does not identify an unknown adulterant, but an unexpected rotation is a reason to run the isomer method. For a disputed lot, NMR can confirm the substitution pattern directly.
For a 40:1 blend, the ratio is calculated from two assays, not from a single total-inositol figure. D-chiro should be measured, not obtained by subtracting myo from the total; the subtraction assumes the only two components are the two isomers, which is exactly the assumption an adulteration check is meant to test.
What IR, melting point and XRD show
IR is the catalog identity test. The spectrum shows the O–H and C–O stretching of the cyclitol and a fingerprint region that can be compared with a reference standard. It is good at confirming that the solid is consistent with myo-inositol and good at flagging a different solid, but it is not an isomer assay and it does not measure how much of a second component is present.
The melting point of 224–227 °C is a second solid-form check. A pure crystalline lot melts in that window; a mixture can melt lower or over a wider range. The test is simple and useful, but it is not specific: another polyol with a similar melting point can pass it.
X-ray diffraction adds a crystal-phase view. It can show the characteristic pattern of myo-inositol and can detect a crystalline adulterant such as sucrose, glucose or sorbitol above its detection limit. It does not see an amorphous adulterant, a fully dissolved one, or a second component below its detection limit. If XRD is used, the report should state the detection limit and the reference pattern; a “no impurity” line without a limit is not evidence.
Sugars, sugar alcohols and other isomers
The commercial incentive to extend an inositol lot is straightforward: glucose, sucrose, maltodextrin, sorbitol and mannitol are common bulking agents, and some of them pass a total-sugar or total-carbohydrate assay. An assay of 99% by a non-specific method is not evidence that the powder is myo-inositol.
| Adulterant | What it does | Test that sees it |
|---|---|---|
| Glucose, sucrose, maltodextrin | Bulks the powder; responds to total-sugar methods | HPLC with RI or ELSD; sugar profile |
| Sorbitol, mannitol, xylitol | Similar polyol behaviour and solubility | HPLC resolution; melting point; XRD |
| D-chiro-inositol | Same formula and mass; meets a total inositol assay | Isomer-resolving HPLC; optical rotation; NMR |
| Scyllo- or neo-inositol | Other cyclitol isomers | Isomer-resolving HPLC; NMR |
The screen should be chosen for the risk, not copied from a template. A sugar profile answers the bulking question; an isomer method answers the myo-versus-D-chiro question; XRD answers the crystalline-solid question. Each report needs its limit of detection and quantification, and a “not detected” line has to be read against that limit.
How to write the specification
- “Myo-inositol, CAS 87-89-8; assay 99.0–101.0% by HPLC; column, mobile phase, detector and standard named.”
- “Identification: IR spectrum conforms to reference; melting point 224–227 °C.”
- “Isomer: D-chiro-inositol not more than the stated limit of quantification when the label claims myo-inositol only.”
- “Loss on drying ≤0.5%; residue on ignition ≤0.1%; heavy metals and microbiology as released.”
- “Adulterant screen: no glucose, sucrose, sorbitol or mannitol above the stated limit.”
- “Particle size ≥95% through 40 mesh; retained sample per lot.”
The specification should distinguish the tests that are run on every lot from the tests that are run on request. An isomer limit and an adulterant screen are only useful if the certificate reports the result and the limit; a specification line without a method is a wish.
Five questions for the supplier
- Which isomer is this lot, and how does the HPLC method resolve myo-inositol from D-chiro-inositol?
- Which detector, column and standard were used, and what are the detection and quantification limits?
- Is the assay reported on an as-is or dried basis, and what are the loss on drying and residue results?
- Is there an IR spectrum and a melting point for this lot, and which reference was used?
- Has the lot been screened for sugars, sugar alcohols and other inositol isomers, and at what limits?
Five direct answers amount to an identity file; a single assay percentage does not. The COA page shows where each figure sits on the certificate, the grade page explains the isomer and mesh choices, and myo versus D-chiro covers the ratio. The inositol product page carries the catalog specification, and the HPLC method note explains the detector choice.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation